- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Successful treatment of chronic hepatitis C with crushed tablet for sofosbuvir/ledipasvir
-
- Sekoguchi Satoru
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Nagao Yasuyuki
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Ikeda Kanami
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Yamane Satoki
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Takemura Keisuke
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Oaku Tatsuro
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Hotta Yuma
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Yamada Nobuhisa
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Isozaki Yutaka
- Department of Gastroenterology, Matsushita Memorial Hospital
-
- Oyamada Hirokazu
- Department of Gastroenterology, Matsushita Memorial Hospital
Bibliographic Information
- Other Title
-
- ソホスブビル/レジパスビル配合錠の粉砕投与を行い著効が得られたC型慢性肝炎の1例
- 症例報告 ソホスブビル/レジパスビル配合錠の粉砕投与を行い著効が得られたC型慢性肝炎の1例
- ショウレイ ホウコク ソホスブビル/レジパスビル ハイゴウジョウ ノ フンサイ トウヨ オ オコナイ チョコウ ガ エラレタ Cガタ マンセイ カンエン ノ 1レイ
Search this article
Description
<p>A 65-year-old woman with early-onset Alzheimer's disease and type 2 diabetes mellitus received a house call from a medical practitioner. Antiviral therapy could be performed for chronic hepatitis C (genotype 2), and she visited our hospital. It was difficult for her to take tablets because of early-onset Alzheimer's disease; therefore, we provided crushed tablets of sofosbuvir/ledipasvir for 12 weeks. HCV-RNA in her blood showed negative conversion 8 weeks after treatment initiation, and SVR 12 was obtained.</p><p>In antiviral therapy against chronic hepatitis C, it is necessary to carefully consider adaptation when treatment is indicated when the patient finds it difficult to take tablets. However, internal treatment with crushed tablets is believed to be an option.</p><p>We report a case of antiviral treatment for chronic hepatitis C wherein it was difficult to take a tablet, and we experienced the case of a patient for whom treatment with crushed tablets was successful.</p>
Journal
-
- Kanzo
-
Kanzo 60 (9), 332-337, 2019-09-01
The Japan Society of Hepatology
- Tweet
Details 詳細情報について
-
- CRID
- 1390845702275825536
-
- NII Article ID
- 130007701681
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL BIB ID
- 029930773
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed